NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ChromaCode

ChromaCode

Private
Carlsbad, CaliforniaHealthcare & Life Scienceshttps://www.chromacode.com/

Last Round

Series A

Extension

Jan 30, 2025

Total Funding Raised

$66.55M

Company Overview

ChromaCode is a molecular diagnostics company that develops a genomics multiplexing platform utilizing High-Definition PCR technology to enable rapid, accurate, and cost-effective molecular diagnostics testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

molecular diagnosticsmultiplexing technologyreal-time PCRqPCRHDPCRdiagnostic assay kitshigh-throughput testingbiomarker detectiondiagnostic softwarerazor-and-blade modelclinical laboratory automationlab-on-a-chipprecision diagnosticsdigital PCRdPCR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ChromaCode Comps

Public and private peers based on sector, stage, and business model.

ChromaCode comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ChromaCode Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 30, 2025
StrategicJun 7, 2023
GrantMar 16, 2021
Series C ExtensionMay 19, 2020
Series CDec 17, 2019
Series B
Apr 27, 2017

Key People

Founding team and executive leadership

Jerrod Schwartz

Chief Technology Officer

Executive Team

ChromaCode Investors

Notable investors and investment history

ChromaCode investors
InvestorRounds
Okapi Venture CapitalSeries B, Series C Extension, Series A, Series C
New Enterprise Associates (NEA)Series C Extension, Series C, Series B
Domain AssociatesSeries B, Series C Extension, Series C, Series A
Moore Venture PartnersSeries C Extension, Series C
Global Brain CorporationStrategic
California Institute of Technology Investment OfficeSeries C Extension, Series C
Northpond VenturesSeries C Extension, Series C

ChromaCode Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ChromaCode Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ChromaCode's valuation, stock price, and market status.

Firmographic Details

HeadquartersCarlsbad, California
Employee Range19
Year Founded2012
Last FundingJan 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.